• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 100 of 100
Laid-Off Workers Get Employment Tips And Free Botox Treatments
FinanceAllergan in talks with another bidder as it looks to thwart Valeant
By Laura LorenzettiNovember 6, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
RetailCVS Health’s tobacco ban hits retail sales after one month
By Laura LorenzettiNovember 4, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
LeadershipSanofi’s CEO ouster: A snowball of bad judgment calls
By Eleanor BloxhamOctober 30, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
LeadershipSanofi fires CEO after profit warning on key drug
By Geoffrey SmithOctober 29, 2014
Google X goes teeny-tiny to diagnose disease at its earliest stages
FeaturesGoogle X goes teeny-tiny to diagnose disease at its earliest stages
By Laura LorenzettiOctober 28, 2014
Pfizer’s sales beats expectations even as top drugs lose patent protections
FinancePfizer’s sales beats expectations even as top drugs lose patent protections
By Laura LorenzettiOctober 28, 2014
NIGERIA-HEALTH-DISEASE-EPIDEMIC-EBOLA-LIBERIA
Technical hurdles, not funding, could hinder race for Ebola vaccines
By ReutersOctober 27, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
FinanceAllergan firms up its profit as it continues to rebuff Valeant’s advances
By Laura LorenzettiOctober 27, 2014
Technology
FinanceMerck’s cost cutting pays off as results beat expectations
By Laura LorenzettiOctober 27, 2014
BRITAIN-PHARMACEUTICAL-GSK
FinanceGlaxoSmithKline moving forward with Ebola vaccine
By Laura LorenzettiOctober 22, 2014
Daniel Loeb urges Amgen to split into two companies
FinanceDaniel Loeb urges Amgen to split into two companies
By ReutersOctober 21, 2014
Management
LeadershipThe top 10 best-performing CEOs
By Laura LorenzettiOctober 17, 2014
77993380
FinanceEnd of the road for inversions? Abbvie drops $55 billion Shire bid
By ReutersOctober 16, 2014
Abbvie looks like dropping Shire bid after crackdown on tax inversions
FinanceAbbvie looks like dropping Shire bid after crackdown on tax inversions
By Geoffrey SmithOctober 15, 2014
Valeant Offers to Buy Allergan With Pershing's Support
FinanceValeant seen raising offer for Allergan to clinch deal
By Geoffrey SmithOctober 8, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Investing
Meet the 2 men putting New York's $300 billion pension fund in play for the first time in 20 yearsplaceholder alt text
By Nick LichtenbergJune 22, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.